Poly ( l ‐lactic acid) bioresorbable scaffolds versus metallic drug‐eluting stents for the treatment of coronary artery disease: A meta‐analysis of 11 randomized trials-Reference-Cited by-同舟云学术

Poly ( l ‐lactic acid) bioresorbable scaffolds versus metallic drug‐eluting stents for the treatment of coronary artery disease: A meta‐analysis of 11 randomized trials

Published:2019-11-15 Issue:4 Volume:96 Page:813-824
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Verdoia Monica¹^ORCID,Kedhi Elvin²,Suryapranata Harry³,Galasso Gennaro⁴,Dudek Dariusz⁵,De Luca Giuseppe¹

Affiliation:

1. Division of Cardiology, Azienda Ospedaliera‐Universitaria “Maggiore della Carità” Eastern Piedmont University Novara Italy

2. Department of Cardiology ISALA Hospital Zwolle the Netherlands

3. Department of Cardiology UMC St Radboud Nijmegen the Netherlands

4. Divisione di Cardiologia Università degli Studi di Salerno Salerno Italy

5. Institue of Cardiology, Jagiellonian University Krakow Poland

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.28594

Reference42 articles.

1. Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials

2. Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With ST Elevation Myocardial Infarction

3. Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty

4. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction

5. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of the Protective Mechanism of Curcumin on Cardiovascular Disease;Drug Design, Development and Therapy;2024-01

2. 24-Month Clinical Follow-Up and Mechanistic Insights From Intravascular Imaging Following Coronary Implantation of the Novel DynamX Bioadaptor Platform;Cardiovascular Revascularization Medicine;2023-01

3. Immediate and Medium-Term (6 Months) Results of BVS Absorb Biodegradable Coronary Scaffolds Installation in Patients with Chronic Forms of Coronary Artery Disease;Russian Sklifosovsky Journal "Emergency Medical Care";2022-10-14

4. Curcumin attenuates inflammation of Macrophage-derived foam cells treated with Poly-L-lactic acid degradation via PPARγ signaling pathway;Journal of Materials Science: Materials in Medicine;2022-03-18

5. Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial;Journal of Clinical Medicine;2021-10-30